openPR Logo
Press release

In-vitro Diagnostics Market Pivotal Players | Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied (Danaher), Grifols, Johnson & Johnson, Luminex, LivaNova (Sorin), Ortho Clinical Diagnostics, F. Hoffmann-La Roche, Siemens

02-12-2019 11:42 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

In-vitro Diagnostics Market

In-vitro Diagnostics Market

Global in-vitro diagnostics market to witness massive demand from infectious disease treatment applications over 2018-2024.

With incredible rise in the occurrence of diseases all around the world, in-vitro diagnostics (IVD) market has gained substantial momentum owing to its significance in detecting varied medical conditions and to expedite treatments. Different tests performed on human blood or tissue samples assist medical professionals to monitor the health of patients and treat, cure or prevent diseases. Prevalence of cancer, diabetes, autoimmune diseases, hepatitis, kidney disorders and a large number of infectious diseases have immensely transformed the in-vitro diagnostics industry landscape, along with influencing vital technological developments. Valued at nearly USD 62.8 billion in 2017, the global in-vitro diagnostics market has been witnessing massive expansion in the diagnosis and treatment of infectious diseases among the growing geriatric population.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/2820

According to WHO estimates, the total population of people aged 60 years or more, will almost double from 900 million in 2015 to approx. 2 billion in 2050. It is a known fact that older people have lower immune systems and are more prone to getting infected, requiring consistent testing for diseases and necessitating the in-vitro diagnostics industry intervention. Mounting cases of infections in younger patients have also mandated the use of efficient diagnostic processes for recognizing and managing the diseases. Heavy R&D investments by healthcare companies and medical institutes have resulted in the discovery of several techniques for testing infections that cause respiratory disorders, diarrheal problems, tuberculosis and AIDS. Infectious diseases are a leading cause of fatalities worldwide and the need for appropriate methods of identifying and dealing with them will profusely advance the in-vitro diagnostics market.

As each disease is attributed to different causes, no unique method can be applied to test for every kind of infection. Considered to be one of the most advanced technology for testing available in the in-vitro diagnostics market, molecular diagnostics has grabbed the attention of key industry players who are seeking to capitalize on its extensive application scope. Becoming a go-to solution in clinical testing for infections, cancers and other disorders, molecular diagnostics has allowed for improved and faster detection of harmful agents in the blood stream. Molecular testing is able to detect even minute amounts of infectious elements in the body, enabling the identification of diseases faster than what was previously possible. Increasingly deployed in detecting infectious diseases as it is a less invasive technique in comparison to performing biopsies, molecular diagnostics technology has presented an extremely lucrative vertical within the in-vitro diagnostics market.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/2820

Elaborating on the potential of molecular diagnostics for managing infections, further WHO reports show that three categories of infectious diseases had been ranked in the top ten causes of deaths worldwide in 2016, namely tuberculosis, diarrheal diseases and lower respiratory infections. Tuberculosis (TB), in particular, had resulted in over 1.7 million deaths from the total of 10.4 million TB cases recorded in the year. Mostly affecting the lungs, TB easily spreads through air and inhaling only a small amount of infectious germs can cause the disease to build up. As such, the in-vitro diagnostics industry has experienced rapid progress in development of efficient testing solutions for early detection of this curable airborne disease. Notable industry collaborations have permitted the advent of affordable and easily accessible molecular diagnostic services to prevent the spread of TB and other infectious illnesses.

A reputed medical research foundation, LifeArc and the University of St Andrews Infection Group recently unveiled a new molecular diagnostic test, which they collaboratively developed for detecting and quantifying TB bacteria among affected patients. The Molecular Bacterial Load Assay (MBLA) test will purportedly use molecular techniques to count the live bacteria and the process is up to get CE-marked so that it can be made available to patients in every region. It is important to detect the onset of TB early and the MBLA is designed to achieve results within hours what traditional methods did in weeks. The in-vitro diagnostics market will largely benefit from the application of molecular diagnostics in treating TB, since international health agencies and governments have committed themselves towards eradicating the TB epidemic by 2030.

All in all, the in-vitro diagnostics industry has made unequivocal contributions towards diagnosing infectious diseases and enabled doctors to create targeted therapies and treatments for patients. Convenient access to superior quality equipment and the emergence of integrated monitoring technologies will further drive the in-vitro diagnostics market, which consists of leading healthcare companies like Abbot, BioRad, Cepheid, Danaher, Johnson & Johnson, Roche Diagnostics, Siemens and Qiagen.

Report Content

Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary
2.1. In-vitro diagnostics industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Type trends
2.1.3. Technology trends
2.1.4. Application trends
2.1.5. End-user trends
2.1.6. Regional trends

Chapter 3. In-vitro Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Growing rate of healthcare infections particularly in North America
3.3.1.2. Increasing adoption rate of automated diagnostic machine & equipment in Europe
3.3.1.3. Rising geriatric population preferring personalized medicines in Asia Pacific
3.3.1.4. Surging number of pathology labs and services equipped with advanced diagnostics machine
3.3.1.5. Increasing awareness regarding viral disease detection in the U.S.
3.3.2. Industry pitfalls and challenges
3.3.2.1. Excessive cost of diagnosis service
3.4. Growth potential analysis
3.4.1. By type
3.4.2. By technology
3.4.3. By application
3.4.4. By end-user
3.5. Regulatory landscape
3.5.1. U.S.
3.5.2. Europe
3.6. Porter’s analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-vitro Diagnostics Market Pivotal Players | Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied (Danaher), Grifols, Johnson & Johnson, Luminex, LivaNova (Sorin), Ortho Clinical Diagnostics, F. Hoffmann-La Roche, Siemens here

News-ID: 1580372 • Views: 572

More Releases from Global Market Insights, Inc.

Global sodium metasilicate pentahydrate market size by 2025 | Top Companies are …
Global Market Insights, Inc., says that sodium metasilicate pentahydrate market may exceed USD 875 million by 2025. Sodium metasilicate pentahydrate market is expected to accrue momentous proceeds from the cement industry. The product is used as a connecting agent in the making of refractory cement & can enable properties such as chemical and heat resistance and hardness. It has also found application in the cosmetic, textile, ceramics, chemical production, and
Vinyl ester market Growth in Europe, Impact Covid19 and Top key players like Swa …
Vinyl ester market to be fueled by increasing deployment of wind energy facilities, Europe to emerge as a pivotal revenue pocket. In 2017, Europe marked a growth of 25% in the wind power plant capacity annual installation as compared to 2016. Whereas wind energy was the second-largest source of power generation power in the year 2016 in Europe. Nations worldwide are actively aligning their focus toward the deployment of wind
Biaxially Oriented Polypropylene (BOPP) Market Size, Share by key players like B …
Biaxially oriented polypropylene (BOPP) market size to reach USD 20 billion by 2024. Growing focus on superior packaging for the protection of delicate good, foods, medicines, and others will favor BOPP business growth in the coming years. Rapid proliferation of e-commerce platforms along with changing consumer spending trends will drive biaxially oriented polypropylene (BOPP) market outlook. In a world of constantly-changing lifestyles, consumers expect products to be shatter-proof, lightweight, aesthetically appealing,
Titanium Dioxide Market to see 7%+ CAGR over 2021-2026 | Key Players are Tronox …
Titanium Dioxide Market growth will be driven by rising expansion activities in the paints & coatings sector and proliferating application in paper & pulp industry. For years, titanium dioxide (TiO₂) has been used in the manufacturing of numerous consumer products across various industries. The product finds applications in paints, adhesives, coatings, paper, rubber, printing inks, textiles, coated fabrics, ceramics, roofing materials, floor coverings, and cosmetics. Surging in product demand across

All 5 Releases


More Releases for Diagnostics

Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Global Influenza Diagnostics Market 2017 : BioMerieux, SA Scientific, Enigma Dia …
Influenza Diagnostics Market 2017 A market study based on the " Influenza Diagnostics Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Influenza Diagnostics Market 2017’. The research report analyses the historical as well as present performance of the worldwide Influenza Diagnostics industry, and makes predictions on the future status of Influenza Diagnostics market on the basis of this analysis. Get Free Sample Copy of
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test